-The New Indian Express Rajesh Aggarwal's Akash plant in Bhimpura near Rampur Industrial Area in Kota earlier produced all kinds of gas materials and supplied them in the local market. JAIPUR: Bold individual efforts have stood in good stead for oxygenstarved Rajasthan. An entrepreneur in the academic coaching city of Kota has found a unique way to tackle the crisis. He has got his factory converted into an oxygen plant in a...

-TheLeaflet.in Explaining the predicament of Micro, Small and Medium Enterprises (MSMEs) when opting for payment claims under the MSME Development Act, 2006, VIVEK SHARMA writes about why, in practice, the statutory compound interest enshrined in the law is rarely executed, and offers suggestions to bolster the law and secure the interests of MSMEs in this regard. MICRO, Small and Medium Enterprises (MSMEs) play a significant role in India’s GDP and export story....

-The Hindu Business Line WTO has allowed countries to issue compulsory licenses during emergencies A Division Bench of the Kerala High Court on Tuesday asked the Centre to respond to a plea for invoking the compulsory licensing to allow other capable vaccine manufacturers to produce Covid vaccines. The Bench comprising Justice Raja Vijayaraghavan and Justice M.R.Anitha passed the directive when a Public Interest litigation in this regard came up for hearing. The petition...

India is facing a second and worse wave of Covid-19 pandemic. At this time, the country requires journalism to tell the stories of courage, of loss and grief, of the state of preparedness and about the efforts being made by communities, individuals, civil society and government. Journalists are needed to document with rigour the gaps and lacunae in governance when it appears. At the same time, journalists need to be vigilant about...

-The Indian Express A waiver on IP protections would mean pharmaceutical firms and vaccine makers across the world can learn how to make these vaccines without fear of lawsuits from companies that originally developed them. In a move that could potentially help increase production of Covid-19 vaccines around the world, the United States on Wednesday announced its support for waiving intellectual property (IP) protections for these vaccines. Subsequently, the European Union (EU) agreed...